However, tumor-infiltrating type I NKT cells exhibit impaired antitumor ability with decreased production of IFN-γ, which indicate that type I NKT cells might switch from a TH1- toward a TH2-like NKT cell subset in TME (105). The gene discussed is IFNG; the disease is neoplasm.